Skip to content

Lucillia Sericata larval therapy in the treatment of diabetic chronic wounds

Lucillia Sericata larval therapy in the treatment of diabetic chronic wounds

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20201012049000N1
Enrollment
70
Registered
2020-12-21
Start date
2020-10-22
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic wound. Diabetes mellitus due to underlying condition

Interventions

Intervention group: 70 patients with diabetic wounds were treated by maggot therapy. First, after washing the wound with saline serum, the area around the wound is covered with zinc oxide ointment. De

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 90 Years

Inclusion criteria

Inclusion criteria: Diabetic patients (more than 15 years old) with chronic wound that signed the informed consent.

Exclusion criteria

Exclusion criteria: Consumption of drugs that influence the wound healing. immunosuppress patients like hemophilia and hepatic disease. scares> 5cm patients with osteomyelitis, cellulitis and cancers. patients who needs amputation or flap surgery. Patients with vascular problems that needs surgery. Wet and new wounds. More than one wound. smoker or burger disease Claudication or vascular graft problems. HbA1C>8 ESR, CRP>+1 anticouagulation therapy. wound under pressure. fear of insects. ecxema or skin allergy history. Chemotherapy or radiotherapy history. Any sensitivity to special drug.

Design outcomes

Primary

MeasureTime frame
Investigation and evaluation of wound size by wound sizing. Timepoint: before intervention and 7 days after. Method of measurement: Evaluation and evaluation of wound size by wound sizing with standard measuring device (strotactic).

Secondary

MeasureTime frame
Inflammation and redness or infection at the site of the wound. Timepoint: before intervention and 7 days after. Method of measurement: Medical visit.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHajar Khazraei

Shiraz University of Medical Sciences

hajarkhazraei@gmail.com009836281453

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026